- Report
- February 2026
- 226 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 194 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 194 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 193 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 193 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 179 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 233 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 192 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 194 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 194 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 354 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 183 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 361 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 245 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- January 2026
- 184 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- August 2025
- 198 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- January 2026
- 180 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- January 2026
- 190 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- January 2026
- 192 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- January 2026
- 191 Pages
Global
From €3458EUR$3,939USD£3,008GBP

The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more